Safety and Efficacy of IBI188 With Azacitidine in Subjects With Newly Diagnosed Higher Risk MDS

NCT04485065 · clinicaltrials.gov ↗

PHASE1

Phase

SUSPENDED

Status

120

Enrollment

INDUSTRY

Sponsor class

Stopped Suspended for changes in development strategy

Conditions

Myelodysplastic Syndromes

Interventions

DRUG: IBI188+azacitidine

Sponsor

Innovent Biologics (Suzhou) Co. Ltd.